Recent advances in the imaging of hepatocellular carcinoma. From ultrasound to poison emission tomography scan

Saudi Medical Journal

Volumn 28, Issue 7, 2007, Pages 1007-1014

  Camaggi, Valeria ^a   Piscaglia, Fabio ^a   Bolondi, Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ALGORITHM; CANCER CLASSIFICATION; CANCER STAGING; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; FALSE POSITIVE RESULT; HUMAN; IMAGE ANALYSIS; LIVER ANGIOGRAPHY; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR VASCULARIZATION; ECHOGRAPHY; LIVER TUMOR; POSITRON EMISSION TOMOGRAPHY;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; ULTRASONOGRAPHY;

EID: 34548379407     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: Summary of a workshop. Hepatology 2002; 36: 227-242.
2. El-Serag HB. Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology 2004; 127: S27-S34.
3. Yoshizawa H, Tanaka J, Miyakawa Y. National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population. Intervirology 2006; 49: 7-17.
4. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study. Gastroenterology 2004; 127: 1372-1380.
5. Livraghi T, Festi D, Monti F, Salmi A, Vettori C. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 1986; 161: 309-312.
6. Sheu JC, Huang GT, Chen DS, Sung JL, Yang PM, Wei TC, et al. Small hepatocellular carcinoma: Intratumor ethanol treatment using new needle and guidance systems. Radiology 1987; 163: 43-48.
7. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101-108.
8. Ebara M, Okabe S, Kita K, Sugiura N, Fukuda H, Yoshikawa M, et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 2005; 43: 458-464.
9. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: Diagnosis and treatment. Gastroenterology 2002; 122: 1609-1619.
10. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
11. Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, Romeo R, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004; 126: 1005-1014.
12. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000; 31: 330-335.
13. Tanaka S, Kitamura T, Nakanishi K, Okuda S, Yamazaki H, Hiyama T, Fujimoto I. Effectiveness of periodic checkup by ultrasonography for the early diagnosis of hepatocellular carcinoma. Cancer 1990; 66: 2210-2214.
14. Colombo M, de Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991; 325: 675-680.
15. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: A cost effectiveness analysis. Gut 2001; 48: 251-259.
16. Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 2003; 39: 1076-1084.
17. Furuya K, Nakamura M, Yamamoto Y, Togei K, Otsuka H. Macroregenerative nodule of the liver. A clinicopathologic study of 345 autopsy cases of chronic liver disease. Cancer 1988; 61: 99-105.
18. Kondo F, Ebara M, Sugiura N, Wada K, Kita K, Hirooka N, et al. Histological features and clinical course of large regenerative nodules: evaluation of their precancerous potentiality. Hepatology 1990; 12: 592-598.
19. Mion F, Grozel L, Boillot O, Paliard P, Berger F. Adult cirrhotic liver explants: Precancerous lesions and undetected small hepatocellular carcinomas. Gastroenterology 1996; 111: 1587-1592.
20. Borzio M, Fargion S, Borzio F, Fracanzani AL, Croce AM, Stroffolini T, et al. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol 2003; 39: 208-214.
21. Kojiro M, Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis 2005; 25: 133-142.
22. Roncalli M. Hepatocellular nodules in cirrhosis: Focus on diagnostic criteria on liver biopsy. A Western experience. Liver Transpl 2004; 10: S9-S15.
23. Nakano M, Saito A, Yamamoto M, Doi M, Takasaki K. Stromal and blood vessel wall invasion in well-differentiated hepatocellular carcinoma. Liver 1997; 17: 41-46.
24. Tomizawa M, Kondo F, Kondo Y. Growth patterns and interstitial invasion of small hepatocellular carcinoma. Pathol Int 1995; 45: 352-358.
25. Inoue K, Takayama T, Higaki T, Watanabe Y, Makuuchi M. Clinical significance of early hepatocellular carcinoma. Liver Transpl 2004; 10: S16-S19.
26. Kimura H, Nakajima T, Kagawa K, Deguchi T, Kakusui M, Katagishi T, et al. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry. Liver 1998; 18: 14-19.
27. Nakashima Y, Nakashima O, Hsia CC, Kojiro M, Tabor E. Vascularization of small hepatocellular carcinomas: Correlation with differentiation. Liver 1999; 19: 12-18.
28. Roncalli M, Roz E, Coggi G, Di Rocco MG, Bossi P, Minola E, et al. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: Implications for diagnosis and classification. Hepatology 1999: 30: 1174-1178.
29. Matsui O, Kadoya M, Kameyama T, Yoshikawa J, Takashima T, Nakanuma Y, et al. Benign and malignant nodules in cirrhotic livers: Distinction based on blood supply. Radiology 1991; 178: 493-497.
30. Hayashi M, Matsui O, Ueda K, Kawamori Y, Kadoya M, Yoshikawa J, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: Evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 1999; 172: 969-976.
31. Takayasu K, Muramatsu Y, Mizuguchi Y, Moriyama N, Ojima H. Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic CT and a combination of CT and angiography: experience with resected liver specimens. Intervirology 2004; 47: 199-208.
32. Matsui O. Imaging of multistep human hepatocarcinogenesis by CT during intra-arterial contrast injection. Intervirology 2004; 47: 271-276.
33. Tochio H, Kudo M. Afferent and efferent vessels of premalignant and overt hepatocellular carcinoma: Observation by color Doppler imaging. Intervirology 2004; 47: 144-153.
34. Matsui O. Detection and characterization of hepatocellular carcinoma by imaging. Clin Gastroenterol Hepatol 2005; 3: S136-S140.
35. Okuda K, Obata H, Jinnouchi S, Kubo Y, Nagasaki Y. Angiographic assessment of gross anatomy of hepatocellular cardinoma: Comparison of celiac angiograms and liver pathology in 100 cases. Radiology 1977; 123: 21-29.
36. Gaiani S, Casali A, Serra C, Piscaglia F, Gramantieri L, Volpe L, et al. Assessment of vascular patterns of small liver mass lesions: Value and limitation of the different Doppler ultrasound modalities. Am J Gastroenterol 2000; 95: 3537-3546.
37. Tanaka S, Kitamura T, Fujita M, Nakanishi K, Okuda S. Color Doppler flow imaging of liver tumors. AJR Am J Roentgenol 1990; 154: 509-514.
38. Kudo M, Tochio H, Zhou P. Differentiation of hepatic tumors by color Doppler imaging: Role of the maximum velocity and the pulsatility index of the intratumoral blood flow signal. Intervirology 2004; 47: 154-161.
39. Kawata S, Murakami T, Kim T, Hori M, Federle MP, Kumano S, et al. Multidetector CT: Diagnostic impact of slice thickness on detection of hypervascular hepatocellular carcinoma. AJR Am J Roentgenol 2002; 179: 61-66.
40. Baron RL, Brancatelli G. Computed tomographic imaging of hepatocellular carcinoma. Gastroenterology 2004; 127: S133-S143.
41. Gaiani S, Celli N, Piscaglia F, Cecilioni L, Losinno F, Giangregorio F, et al. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 2004; 41: 421-426.
42. Jeong YY, Yim NY, Kang HK. Hepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: Imaging spectrum and pitfalls of cirrhosis-related nodules. AJR Am J Roentgenol 2005; 185: 1024-1032.
43. Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 2005; 11: 281-289.
44. Kim HJ, Kim AY, Kim TK, Byun JH, Won HJ, Kim KW, et al. Transient hepatic attenuation differences in focal hepatic lesions: Dynamic CT features. AJR Am J Roentgenol 2005; 184: 83-90.
45. Hayashi PH, Trotter JF, Forman L, Kugelmas M, Steinberg T, Russ P, et al. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadaveric liver allocation in the era of MELD. Liver Transpl 2004; 10: 42-48.
46. Yu JS, Kim KW, Sung KB, Lee JT, Yoo HS. Small arterial-portal venous shunts: A cause of pseudolesions at hepatic imaging. Radiology 1997; 203: 737-742.
47. Ichikawa T. MRI in the evaluation of hepatocellular nodules: Role of pulse sequences and contrast agents. Intervirology 2004; 47: 252-270.
48. Taouli B, Losada M, Holland A, Krinsky G. Magnetic resonance imaging of hepatocellular carcinoma. Gastroenterology 2004; 127: S144-S152.
49. Krinsky GA, Lee VS. MR imaging of cirrhotic nodules. Abdom Imaging 2000; 25: 471-482.
50. Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R, et al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: An explant correlation. Hepatology 2003; 38: 1034-1042.
51. Yu JS, Kim MJ. Hepatocellular carcinoma: Contrast-enhanced MRI. Abdom Imaging 2002; 27: 157-167.
52. Jeong YY, Mitchell DG, Kamishima T. Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 2002; 178: 1327-1334.
53. Krinsky GA, Lee VS, Theise ND, Weinreb JC, Morgan GR, Diflo T, et al. Transplantation for hepatocellular carcinoma and cirrhosis: Sensitivity of magnetic resonance imaging. Liver Transpl 2002; 8: 1156-1564.
54. Rode A, Bancel B, Douek P, Chevallier M, Vilgrain V, Picaud G, et al. Small nodule detection in cirrhotic livers: Evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001; 25: 327-336.
55. Libbrecht L, Bielen D, Verslype C, Vanbeckevoort D, Pirenne J, Nevens F, et al. Focal lesions in cirrhotic explant livers: Pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002; 8: 749-761.
56. Suto Y, Shimatani Y. Dual contrast magnetic resonance imaging with combined use of positive and negative contrast agent in human hepatocellular carcinoma. Br J Radiol 1995; 68: 116-120.
57. Ward J, Guthrie JA, Scott DJ, Atchley J, Wilson D, Davies MH, et al. Hepatocellular carcinoma in the cirrhotic liver: Double-contrast MR imaging for diagnosis. Radiology 2000; 216: 154-162.
58. Lee JY, Choi BI, Han JK, Lee JM, Kim SH. State-of-the-art ultrasonography of hepatocellular carcinoma. Eur J Radiol 2006; 58: 177-185.
59. Choi BI, Kim TK, Han JK, Kim AY, Seong CK, Park SJ. Vascularity of hepatocellular carcinoma: Assessment with contrast-enhanced second-harmonic versus conventional power Doppler US. Radiology 2000; 214: 381-386.
60. Fracanzani AL, Burdick L, Borzio M, Roncalli M, Bonelli N, Borzio F, et al. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology 2001; 34: 1109-1112.
61. Albrecht T, Blomley M, Bolondi L, Claudon M, Correas JM, Cosgrove D, et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 2004; 25: 249-256.
62. Dalla Palma L, Bertolotto M, Quaia E, Locatelli M. Detection of liver metastases with pulse inversion harmonic imaging: Preliminary results. Eur Radiol 1999; 9: S382-S387.
63. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: Improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000; 35: 58-71.
64. Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: The problem of hypovascular hepatocellular carcinoma. Hepatology 2005; 42: 27-34.
65. Wen YL, Kudo M, Zheng RQ, Ding H, Zhou P, Minami Y, et al. Characterization of hepatic tumors: Value of contrast-enhanced coded phase-inversion harmonic angio. AJR Am J Roentgenol 2004; 182: 1019-1026.
66. Dill-Macky MJ, Burns PN, Khalili K, Wilson SR. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology 2002; 222: 95-102.
67. Piscaglia F, Bolondi L; Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: Retrospective analysis of 23188 investigations. Ultrasound Med Biol 2006; 32: 1369-1375.
68. Bruix J, Sherman M, Practice guidelines committee, American Association for the study of liver diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236.
69. Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996; 23: 1641-1674.
70. Schoder H, Erdi YE, Larson SM, Yeung HW. PET/CT: A new imaging technology in nuclear medicine. Eur J Nucl Med Mol Imaging 2003; 30: 1419-1437.
71. Trojan J, Schroeder O, Raedle J, Baum RP, Herrmann G, Jacobi V, et al. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol 1999; 94: 3314-3319.
72. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430.